Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Oncology

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijo.2011.897PMID 21225226
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

  2009cited by this paper
• Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.

  2009cited by this paper
• Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration

  2009cited by this paper
• Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton.

  2009cited by this paper
• Integrin αvβ3/c-src “Oncogenic Unit” Promotes Anchorage-independence and Tumor Progression

  2009cited by this paper
• Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling

  2008cited by this paper
• Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.

  2007cited by this paper
• Src phosphorylates Tyr284 in tgf-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion

  2007cited by this paper
• Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).

  2007cited by this paper
• Transforming growth factor-beta1 effects on endothelial monolayer permeability involve focal adhesion kinase/Src.

  2007cited by this paper
• Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function

  2007cited by this paper
• Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.

  2006cited by this paper
• β3 Integrin and Src facilitate transforming growth factor-β mediated induction of epithelial-mesenchymal transition in mammary epithelial cells

  2006cited by this paper
• Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.

  2006cited by this paper
• Src Activation Is Not Necessary for Transforming Growth Factor (TGF)-β-mediated Epithelial to Mesenchymal Transitions (EMT) in Mammary Epithelial Cells

  2006cited by this paper
• Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38.

  2006cited by this paper
• Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.

  2006cited by this paper
• Pyrazolo–pyrimidine‐derived c‐Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling

  2006cited by this paper
• Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.

  2005cited by this paper
• Adhesion and Rac1-dependent Regulation of Biglycan Gene Expression by Transforming Growth Factor-β

  2005cited by this paper
• Inhibition of Src Tyrosine Kinase Impairs Inherent and Acquired Gemcitabine Resistance in Human Pancreatic Adenocarcinoma Cells

  2004cited by this paper
• Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude Mice

  2004cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-β family signalling

  2003cited by this paper
• The specificities of protein kinase inhibitors: an update.

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

  2003cited by this paper
• Src family kinases in tumor progression and metastasis

  2003cited by this paper
• Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness.

  2003cited by this paper
• Smad‐dependent GADD45β expression mediates delayed activation of p38 MAP kinase by TGF‐β

  2002cited by this paper
• Smad4/DPC4-dependent Regulation of Biglycan Gene Expression by Transforming Growth Factor-β in Pancreatic Tumor Cells*

  2002cited by this paper
• SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

  2002cited by this paper
• Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation.

  2002cited by this paper
• Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta.

  2002cited by this paper
• p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration.

  2002cited by this paper
• Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.

  2001cited by this paper
• Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.

  2001cited by this paper
• TGF‐β–induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase‐2 and the urokinase plasminogen activator system

  2001cited by this paper
• TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation

  2000cited by this paper
• Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype.

  2000cited by this paper
• TGFbeta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression.

  1999cited by this paper
• Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma.

  1998cited by this paper
• Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells.

  1998cited by this paper
• Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma.

  1998cited by this paper
• Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival

  1993cited by this paper
• Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival.

  1993cited by this paper
• Pancreatic carcinoma.

  1992cited by this paper

• Recent advances of small-molecule c-Src inhibitors for potential therapeutic utilities.

  2023cites this paper
• The type II TGF-β receptor phosphorylates Tyr182 in the type I receptor to activate downstream Src signaling

  2022cites this paper
• Exploration of the System-Level Mechanisms of the Herbal Drug FDY003 for Pancreatic Cancer Treatment: A Network Pharmacological Investigation

  2022cites this paper
• Heterogeneity in PHGDH protein expression potentiates cancer cell dissemination and metastasis

  2021cites this paper
• Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations

  2020cites this paper
• Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis

  2019cites this paper
• The role of small GTPases of the Rho/Rac family in TGF‐β‐induced EMT and cell motility in cancer

  2018cites this paper
• Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis

  2018cites this paper
• Endoplasmic reticulum stress activates SRC, relocating chaperones to the cell surface where GRP78/CD109 blocks TGF-β signaling

  2018cites this paper
• The anti-tumorigenic activity of A2M—A lesson from the naked mole-rat

  2017cites this paper
• Lawrence Berkeley National Laboratory Recent Work Title The component formula of Salvia miltiorrhiza and Panax ginseng induces apoptosis and inhibits cell invasion and migration through targeting PTEN in lung cancer cells

  2017cites this paper
• The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma

  2017cites this paper
• TGF-β Signal Transduction in Pancreatic Carcinoma Cells is Sensitive to Inhibition by the Src Tyrosine Kinase Inhibitor AZM475271.

  2017cites this paper
• TGF-β1-induced cell migration in pancreatic carcinoma cells is RAC1 and NOX4-dependent and requires RAC1 and NOX4-dependent activation of p38 MAPK.

  2017cites this paper
• The component formula of Salvia miltiorrhiza and Panax ginseng induces apoptosis and inhibits cell invasion and migration through targeting PTEN in lung cancer cells

  2017cites this paper
• Antihepatocellular Carcinoma Potential of Tetramethylpyrazine Induces Cell Cycle Modulation and Mitochondrial-Dependent Apoptosis

  2016cites this paper
• TGFβ induces epithelial‐mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways

  2016influential citation
• Capsaicin Inhibited Aggressive Phenotypes through Downregulation of Tumor-Associated NADH Oxidase (tNOX) by POU Domain Transcription Factor POU3F2

  2016cites this paper
• Design Strategies, Structures and Molecular Interactions of Small Molecule Src Inhibitors.

  2016cites this paper
• Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action

  2015cites this paper
• Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β

  2015cites this paper
• Molecular mechanisms for activation of non-canonical TGFβ pathways and their importance during prostate cancer progression

  2015cites this paper
• TGFβ1 rapidly activates Src through a non-canonical redox signaling mechanism.

  2015cites this paper
• Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas

  2014cites this paper
• Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness.

  2014cites this paper
• Transforming growth factor-beta1 signaling blockade attenuates gastric cancer cell-induced peritoneal mesothelial cell fibrosis and alleviates peritoneal dissemination both in vitro and in vivo

  2014cites this paper
• Nox 4-derived ROS Signaling Contributes to TGF-β-induced Epithelial-mesenchymal Transition in Pancreatic Cancer Cells

  2013cites this paper
• Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells.

  2013cites this paper
• Impedance measurements in the biomedical sciences.

  2013cites this paper
• Stratum basale keratinocyte expression of the cell‐surface glycoprotein CDCP1 during epidermogenesis and its role in keratinocyte migration

  2013cites this paper
• A Real Time Chemotaxis Assay Unveils Unique Migratory Profiles amongst Different Primary Murine Macrophages

  2013cites this paper
• Src as the link between inflammation and cancer

  2013cites this paper
• Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin

  2013cites this paper
• Characterization of Spontaneous and TGF-β-Induced Cell Motility of Primary Human Normal and Neoplastic Mammary Cells In Vitro Using Novel Real-Time Technology

  2013cites this paper
• Chemotherapeutic agents enhance cell migration and epithelial-to-mesenchymal transition through transient up-regulation of tNOX (ENOX2) protein.

  2012cites this paper
• Phosphorylation of serine-504 of tNOX (ENOX2) modulates cell proliferation and migration in cancer cells.

  2012cites this paper
• The Signaling Mechanism of TGF-β1 Induced Bovine Mammary Epithelial Cell Apoptosis

  2012cites this paper
• Erratum for: Cytotoxic evaluation of alkaloids and isoflavonoids from the Australian tree Erythrina vespertilio

  2012cites this paper
• Src-mediated regulation of E-cadherin and EMT in pancreatic cancer.

  2012cites this paper
• Cytotoxic Evaluation of Alkaloids and Isoflavonoids from the Australian Tree Erythrina vespertilio

  2012cites this paper
• The Src family kinase inhibitors PP2 and PP1 effectively block TGF-beta1-induced cell migration and invasion in both established and primary carcinoma cells

  2012cites this paper
• Timelapse Monitoring of Cell Behavior as a Tool in Tissue Engineering

  2011cites this paper
• Real-time profiling of NK cell killing of human astrocytes using xCELLigence technology.

  2011cites this paper
• Interaction of tumor cells with the microenvironment

  2011influential citation
• The Role of Acidic Fibroblast Growth Factor and Fibroblast Growth Factor Receptor 4 in High Grade Serous Carcinoma

  2011cites this paper
• Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation.

  2011cites this paper
• mall peptides derived from somatotropin domain-containing proteins inhibit lood and lymphatic endothelial cell proliferation , migration , adhesion and tube ormation

  2011cites this paper